References
- Reed SD, Newton KM, Clinton WL, et al. Incidence of endometrial hyperplasia. Am J Obstet Gynecol 2009;200:678. e1–6
- Jobling T, Mamers P, Healy DL, et al. A prospective study of inhibin in granulosa cell tumors of the ovary. Gynecol Oncol 1994;55:285–9
- Chechia A, Attia L, Temime RB, et al. Incidence, clinical analysis, and management of ovarian fibromas and fibrothecomas. Am J Obstet Gynecol 2008;199:473. e1–4
- Su HM, Hu C, Tsay DG, Peng NJ. Ovarian thecoma mimicking carcinoma on F-18 FDG PET in a postmenopausal woman with elevated CA-125. Clin Nucl Med 2011;36:1133–4
- Keeney GL. Ovarian tumors with endocrine manifestations. In: De Groot LJ, ed. Endocrinology. 4th ed. Philadelphia: WB Saunders Company; 2001:2172
- Siekierska-Hellmann M, Sworczak K, Babińska A, Wojtylak S. Ovarian thecoma with androgenic manifestations in a postmenopausal woman. Gynecol Endocrinol 2006;22:405–8
- Park JW, Bae JW. Postmenopausal Meigs’ syndrome in Elevated CA-125: a case report. J Menopausal Med 2015;21:56–9
- Troiano RN, Lazzarini KM, Scoutt LM, et al. Fibroma and fibrothecoma of the ovary: MR imaging findings. Radiology 1997;204:795–8
- Renaud MC, Plante M, Roy M. Ovarian thecoma associated with a large quantity of ascites and elevated serum CA 125 and CA 15-3. J Obstet Gynaecol Can 2002;24:963–5
- Elghorori MR, Al-Taher H, Redwood NF. Ovarian fibrothecoma: a benign neoplasm with potential adverse consequences. J Obstet Gynaecol 2003;23:677–8
- Nocito AL, Sarancone S, Bacchi C, Tellez T. Ovarian thecoma: clinicopathological analysis of 50 cases. Ann Diagn Pathol 2008;12:12–6
- Wu L, Zhang W, Li H, et al. Clinical analysis of 74 cases with ovarian thecoma. Zhonghua Fu Chan Ke Za Zhi 2002;37:101–3
- Burandt E, Young RH. Thecoma of the ovary: a report of 70 cases emphasizing aspects of its histopathology different from those often portrayed and its differential diagnosis. Am J Surg Pathol 2014;38:1023–32
- Cho YJ, Lee HS, Kim JM, et al. Ovarian-sparing local mass excision for ovarian fibroma/fibrothecoma in premenopausal women. Eur J Obstet Gynecol Reprod Biol 2015;185:78–82
- Zanagnolo V, Pasinetti B, Sartori E. Clinical review of 63 cases of sex cord stromal tumors. Eur J Gynaecol Oncol 2004;25:431–8
- McCluggage WG. Recent advances in immunohistochemistry in the diagnosis of ovarian neoplasms. J Clin Pathol 2000;53:327–34
- Movahedi-Lankarani S, Kurman RJ. Calretinin, a more sensitive but less specific marker than alpha-inhibin for ovarian sex cord-stromal neoplasms: an immunohistochemical study of 215 cases. Am J Surg Pathol 2002;26:1477–83